Major Rugby Recalls 12 Levothyroxine Tablet Packages Nationwide Over Subpotency
Updated
Updated · USA TODAY · Jul 27
Major Rugby Recalls 12 Levothyroxine Tablet Packages Nationwide Over Subpotency
2 articles · Updated · USA TODAY · Jul 27
Summary
Twelve levothyroxine sodium tablet packages sold under the Major and Cardinal brands were recalled nationwide after Major Rugby said the prescription thyroid drug was subpotent.
The affected tablets deliver less medication than labeled, according to the company’s retailer letter and an FDA report, prompting advice for consumers to return them to the place of purchase.
Major Rugby said taking the recalled medicine is not likely to cause adverse health effects, but patients who find affected product in their cabinets should consult a doctor.
The recalled lots include 10-tablet and 100-tablet blister packages in strengths from 25 mcg to 150 mcg that were distributed nationwide beginning in January 2025.